Major bleeding rates in atrial fibrillation patients on single, dual, or triple antithrombotic therapy: results from a Nationwide Danish Cohort Study N van Rein, U Heide-Jørgensen, WM Lijfering, OM Dekkers, HT Sørensen, ... Circulation 139 (6), 775-786, 2019 | 170 | 2019 |
Road traffic accidents and psychotropic medication use in the Netherlands: a case–control study S Ravera, N van Rein, JJ De Gier, LTW de Jong‐van den Berg British journal of clinical pharmacology 72 (3), 505-513, 2011 | 109 | 2011 |
Efficacy and safety of vitamin K-antagonists (VKA) for atrial fibrillation in non-dialysis dependent chronic kidney disease J Kooiman, N van Rein, B Spaans, KAJ van Beers, JR Bank, ... PLoS One 9 (5), e94420, 2014 | 59 | 2014 |
Global use of idarucizumab in clinical practice: outcomes of the RE-VECTO surveillance program J Fanikos, D Murwin, F Gruenenfelder, I Tartakovsky, LR França, ... Thrombosis and haemostasis 120 (01), 027-035, 2020 | 46 | 2020 |
Relationship between neighborhood socioeconomic status and venous thromboembolism: results from a population‐based study D Kort, N Van Rein, FJM Van Der Meer, HW Vermaas, N Wiersma, ... Journal of Thrombosis and Haemostasis 15 (12), 2352-2360, 2017 | 45 | 2017 |
Female sex as a risk modifier for stroke risk in atrial fibrillation: using CHA2DS2-VASc versus CHA2DS2-VA for stroke risk stratification in atrial fibrillation: a note of caution PB Nielsen, TF Overvad Thrombosis and haemostasis 120 (06), 894-898, 2020 | 39 | 2020 |
Persistence of oral anticoagulant treatment for atrial fibrillation in the Netherlands: a surveillance study GD Zielinski, N van Rein, M Teichert, FA Klok, FR Rosendaal, ... Research and Practice in Thrombosis and Haemostasis 4 (1), 141-153, 2020 | 39 | 2020 |
Performance of idarucizumab as antidote of dabigatran in daily clinical practice SJ van der Wall, N van Rein, B van den Bemt, MJHA Kruip, K Meijer, ... EP Europace 21 (3), 414-420, 2019 | 39 | 2019 |
Suspected tuberculosis case detection and referral in private pharmacies in Viet Nam DH Vu, N Van Rein, FGJ Cobelens, TTH Nguyen, VH Le, J Brouwers The International journal of tuberculosis and lung disease 16 (12), 1625-1629, 2012 | 37 | 2012 |
Disturbed development of the enteric nervous system after in utero exposure of selective serotonin re‐uptake inhibitors and tricyclic antidepressants. Part 2: Testing … CM Nijenhuis, PGJ ter Horst, N van Rein, B Wilffert, ... British journal of clinical pharmacology 73 (1), 126-134, 2012 | 37 | 2012 |
Major bleeding risks of different low‐molecular‐weight heparin agents: a cohort study in 12 934 patients treated for acute venous thrombosis N van Rein, JS Biedermann, FJM Van der Meer, SC Cannegieter, ... Journal of Thrombosis and Haemostasis 15 (7), 1386-1391, 2017 | 35 | 2017 |
Objectives and design of BLEEDS: a cohort study to identify new risk factors and predictors for major bleeding during treatment with vitamin K antagonists N van Rein, WM Lijfering, MHA Bos, MH Herruer, HW Vermaas, ... PloS one 11 (12), e0164485, 2016 | 34 | 2016 |
Statins and risk of bleeding: an analysis to evaluate possible bias due to prevalent users and healthy user aspects N van Rein, SC Cannegieter, S le Cessie, FR Rosendaal, PH Reitsma, ... American journal of epidemiology 183 (10), 930-936, 2016 | 31 | 2016 |
Inter‐and intra‐individual concentrations of direct oral anticoagulants: the KIDOAC study MMA Toorop, N van Rein, MC Nierman, HW Vermaas, MV Huisman, ... Journal of Thrombosis and Haemostasis 20 (1), 92-103, 2022 | 30 | 2022 |
Self‐reported therapy adherence and predictors for nonadherence in patients who switched from vitamin K antagonists to direct oral anticoagulants MMA Toorop, N van Rein, MC Nierman, HW Vermaas, MV Huisman, ... Research and Practice in Thrombosis and Haemostasis 4 (4), 586-593, 2020 | 25 | 2020 |
Vitamin supplementation on the risk of venous thrombosis: results from the MEGA case-control study BA Vučković, N Van Rein, SC Cannegieter, FR Rosendaal, WM Lijfering The American journal of clinical nutrition 101 (3), 606-612, 2015 | 25 | 2015 |
Clinical outcomes in patients with dilated cardiomyopathy and ventricular tachycardia K Zeppenfeld, AP Wijnmaalen, M Ebert, SH Baldinger, A Berruezo, ... Journal of the American College of Cardiology 80 (11), 1045-1056, 2022 | 24 | 2022 |
Driving performance of depressed patients who are untreated or receive long-term antidepressant (SSRI/SNRI) treatment NN van der Sluiszen, M Wingen, A Vermeeren, F Vinckenbosch, ... Pharmacopsychiatry 50 (05), 182-188, 2017 | 22 | 2017 |
Prescriptive contraceptive use among isotretinoin users in the Netherlands in comparison with non‐users: a drug utilisation study HJMJ Crijns, N van Rein, CC Gispen‐de Wied, SM Straus, ... pharmacoepidemiology and drug safety 21 (10), 1060-1066, 2012 | 22 | 2012 |
Suspected survivor bias in case–control studies: stratify on survival time and use a negative control N van Rein, SC Cannegieter, FR Rosendaal, PH Reitsma, WM Lijfering Journal of clinical epidemiology 67 (2), 232-235, 2014 | 21 | 2014 |